Report overview
Cancer antigens are certain types of proteins secreted into the bloodstream and can be measured in both cancers and non-cancerous conditions. Cancer antigens are the tumour markers produced by cancer cells and other cells of the body which provides information about cancer.
This report aims to provide a comprehensive presentation of the global market for Cancer Antigen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Antigen. This report contains market size and forecasts of Cancer Antigen in global, including the following market information:
Global Cancer Antigen Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Antigen market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cancer Antigen 125 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Antigen include Thermo Fisher Scientific, Roche, Tellgen, Labor Diagnostika Nord, Henso Medical (Hangzhou), Multisciences (Lianke) Biotech, Hangzhou AllTest Biotech, SHINJIN Medics and Xiamen Baysen Medica Tech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Antigen companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Antigen Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cancer Antigen Market Segment Percentages, by Type, 2022 (%)
Cancer Antigen 125
Cancer Antigen 15-3
Cancer Antigen 27-29
Cancer Antigen 19-9
Others
Global Cancer Antigen Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cancer Antigen Market Segment Percentages, by Application, 2022 (%)
Hospitals
Diagnostic Centres
Ambulatory Surgical Centres
Others
Global Cancer Antigen Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cancer Antigen Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Antigen revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Antigen revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Roche
Tellgen
Labor Diagnostika Nord
Henso Medical (Hangzhou)
Multisciences (Lianke) Biotech
Hangzhou AllTest Biotech
SHINJIN Medics
Xiamen Baysen Medica Tech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Antigen, market overview.
Chapter 2: Global Cancer Antigen market size in revenue.
Chapter 3: Detailed analysis of Cancer Antigen company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Antigen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
